The role of CYP2C9 genetic polymorphisms in the oxidative metabolism of diclofenac in vitro

ISSN： 0031-7144

Source： Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol.69, Iss.12, 2014-12, pp. : 898-903

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Genetic Polymorphisms in Cytochrome P450 (CYP) 2C9 and CYP2C8 on the Pharmacokinetics of Oral Antidiabetic Drugs: Clinical Relevance

By Kirchheiner Julia Roots Ivar Goldammer Mark Rosenkranz Bernd

Clinical Pharmacokinetics, Vol. 44, Iss. 12, 2005-01 ,pp. : 1209-1225

Adis International

Access to resources Recommend Favorite

Is diclofenac a valuable CYP2C9 probe in humans?

By Morin S. Loriot M.A. Poirier J.M. Tenneze L. Beaune P.H. Funck-Brentano C. Jaillon P. Becquemont L.

European Journal of Clinical Pharmacology, Vol. 56, Iss. 11, 2001-01 ,pp. : 793-797

Springer Publishing Company

Access to resources Recommend Favorite

Association of Genetic Polymorphisms of CYP2C9 and VKORC1 with Bleeding Following Warfarin: A Case-Control Study

Current Clinical Pharmacology, Vol. 11, Iss. 1, 2016-02 ,pp. : 62-68

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetic Prediction of Individual Variability in Drug Response Based on CYP2D6, CYP2C9 and CYP2C19 Genetic Polymorphisms

Current Drug Metabolism, Vol. 15, Iss. 7, 2014-09 ,pp. : 711-718

Bentham Science Publishers

Access to resources Recommend Favorite

Warfarin: CYP2C9 polymorphisms increase risk of bleeding events

Inpharma, Vol. 1, Iss. 1333, 2002-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite